Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 11/2011

01-11-2011 | Meeting report

“Tumor immunology meets oncology (TIMO) VII” from 15th to 16th of April 2011 in Halle/Saale, Germany

Authors: Juergen Bukur, Elfriede Noessner, Barbara Seliger

Published in: Cancer Immunology, Immunotherapy | Issue 11/2011

Login to get access

Excerpt

German and international experts in the field of immunology and oncology came together from April 15th to 16th 2011 for the 7th multidisciplinary Symposium “Tumor Immunology meets Oncology (TIMO)” with the vision that interdisciplinary work will ultimately lead to success in the treatment for cancer. …
Metadata
Title
“Tumor immunology meets oncology (TIMO) VII” from 15th to 16th of April 2011 in Halle/Saale, Germany
Authors
Juergen Bukur
Elfriede Noessner
Barbara Seliger
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 11/2011
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-011-1102-7

Other articles of this Issue 11/2011

Cancer Immunology, Immunotherapy 11/2011 Go to the issue

Original article

Vaccination of patients with cutaneous melanoma with telomerase-specific peptides

Review

Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma

Original article

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™

Original article

Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation

Original article

Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide

Short communication

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits